Gary Charles Robb. - 19 Sep 2023 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Business Officer
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Gary Charles Robb.
Issuer symbol
CORT
Transactions as of
19 Sep 2023
Net transactions value
-$163,677
Form type
4
Filing time
20 Sep 2023, 18:06:02 UTC
Previous filing
18 Sep 2023
Next filing
05 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Sale $163,677 -5,000 -19% $32.74 21,996 19 Sep 2023 Direct F1, F2
holding CORT Common Stock 8,061 19 Sep 2023 Custodial Account for Child F3
holding CORT Common Stock 8,061 19 Sep 2023 Custodial Account for Child F3
holding CORT Common Stock 8,061 19 Sep 2023 Custodial Account for Child F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average sale price for entire number of shares sold. The actual sale prices range from $32.72 to $32.79. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
F2 Includes 1,600 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2023, 2,091 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2023, and 500 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2023. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F3 These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.